Evidence map›Paper›PMID 28178600›Full record

ArticleThe Journal of nutritional biochemistry2017

Whole flaxseed diet alters estrogen metabolism to promote 2-methoxtestradiol-induced apoptosis in hen ovarian cancer.

Anushka Dikshit, Karen Hales, Dale Buchanan Hales

Open access · greenAbstract read
In one paragraph

Article in The Journal of nutritional biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Anti-Oxidant and Anti-Cancer Properties of Flaxseed.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anushka DikshitDepartment of Physiology, Southern Illinois School of Medicine, Carbondale, IL, 62901, USA.
Karen HalesDepartment of Physiology, Southern Illinois School of Medicine, Carbondale, IL, 62901, USA.
Dale Buchanan HalesDepartment of Physiology, Southern Illinois School of Medicine, Carbondale, IL, 62901, USA. Electronic address: dhales@siumed.edu.
Southern Illinois University School of Medicine · US

Funding

Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian CancerR01AT005295 · NCCIH · SOUTHERN ILLINOIS UNIVERSITY CARBONDALE · PI HALES, DALE B · 2011 to 2015
$1.8M
NCCIH NIH HHS R01 AT005295
6 · The paper itself

Abstract

The study reported here demonstrates that a flaxseed-supplemented diet causes ovarian tumors in the laying hen to undergo apoptosis, resulting in a reduction of tumor burden, reducing the frequency and severity of ovarian cancer. We have previously shown in normal ovaries that flaxseed and its components down-regulate ERalpha and alter the expression of enzymes that metabolize estrogen. In this study, we analyzed the effects of the two main components of whole flaxseed, ligan and omega 3 fatty acids on estrogen metabolism and the estrogen receptor in ovarian tumors. ER alpha expression was up-regulated in the ovarian tumors and was not affected by diet. Liver CYP1A1 expression was significantly increased by the whole flaxseed diet with a corresponding increase in 2-methoxyestradiol plasma levels. We also observed increased p38 and ERK 1/2 MAPK activation in the ovary as well as an increase in apoptosis in the tumor epithelium. SMAD 7, a factor involved in the 2-methoxyestradiol-mediated apoptosis pathway was also up-regulated in tumors from the whole flaxseed diet group. 2-methoxyestradiol-induced antitumor effects were further validated by in human ovarian cancer cells. This study details the effect of flaxseed diet on estrogen metabolism and demonstrates the antiovarian cancer effects of 2-methoxyestradiol.

Indexed as

Flax2-MethoxyestradiolAnimalsApoptosisCaspase 3Cell Line, TumorChickensCytochrome P-450 CYP1B1Cytochrome P-450 CYP3ADietary SupplementsEstradiolEstrogen Receptor alphaFemaleHumansOvarian NeoplasmsOvary2-MethoxyestradiolCaspase 3Cytochrome P-450 CYP1B1Cytochrome P-450 CYP3AEstradiolEstrogen Receptor alphap38 Mitogen-Activated Protein KinasesSmad7 Protein2-MethoxtestradiolApoptosisEstrogen metabolismFlaxseedOvarian cancer

Identifiers

PMID28178600
PMCPMC5360509
OpenAlexW2580762211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.